Home - Scioto :: Scioto

Activated Bacterial Therapeutics Platform

Through Innovative Technology

The Scioto Platform is a novel formulation that primes the colony-forming mechanisms of live bacteria therapeutics by combining beneficial bacteria with polysaccharide microspheres. These natural mechanisms induce ‘biofilm’ formation, enhance function and allow for non-spore forming bacteria to survive passage through the gastrointestinal system.

The Story Behind Scioto

Mission First-in-Class Pipeline

Scioto is developing innovative therapies devoted to having a significant impact on the delivery of microbiome therapeutics.

Our unique Activated Bacterial Therapeutic (ABT) platform leverages live therapeutic bacteria biofilms pre-colonized on microspheres allowing for enhanced function and persistent benefit.

Research and Development

In the Press

Scioto Biosciences Presents Single-dose, Single Strain Pre-clinical C. diff Intervention at American Academy of Pediatrics National Conference & Exhibition
In the Press

THE ROLE OF BIOFILMS: An Interview with Scioto Biosciences
In the Press

A Better Way to Adminster Probiotics

No announcement available or all announcement expired.

Activated Bacterial Therapeutics Platform

Through Innovative Technology

Mission First-in-Class Pipeline

Scioto Biosciences Presents Single-dose, Single Strain Pre-clinical C. diff Intervention at American Academy of Pediatrics National Conference & Exhibition

THE ROLE OF BIOFILMS: An Interview with Scioto Biosciences

A Better Way to Adminster Probiotics